F2g Ltd
03578625
Notable Risks
- 3 outstanding charges (-6)
Details
Compliance
Last accounts
31/12/2024
group
Next accounts due
30/09/2026
Confirmation statement
Last: 10/06/2025
Due 24/06/2026
Industry
Officers
secretary · Since 05/02/2013
director · Since 01/04/2019
PHARMACEUTICAL EXECUTIVE, NON-EXECUTIVE
DUTCH · SWITZERLAND · Age 63
director · Since 11/08/2020
DIRECTOR
BRITISH · UNITED KINGDOM · Age 57
Also on 6 other boards
director · Since 08/09/2021
INDEPENDENT INDUSTRIAL ADVISOR, HEALTHCA
DANISH · SWITZERLAND · Age 54
director · Since 14/12/2021
PHARMACEUTICAL EXECUTIVE
AMERICAN,CANADIAN · UNITED STATES · Age 64
director · Since 29/11/2024
VENTURE CAPITALIST
AMERICAN · UNITED STATES · Age 62
Charges3 outstanding
EUROPEAN INVESTMENT BANK
EUROPEAN INVESTMENT BANK
K/S BI BIOMEDICAL VENTURE ANNEX III MERIFIN CAPITAL N.V. K NOMINEES LIMITED AND ASTELLAS VENTUR
AKCROS CHEMICALS LIMITED
K/S BI BIOMEDICAL VENTURE ANNEX III, MERIFIN CAPITAL N.V, K NOMINEES LIMITED(THE LENDERS)
AKCROS CHEMICALS LIMITED
P/S BI BIOMEDICINSK VENTURE III, MERIFIN CAPITAL N.V. AND K NOMINEES
P/S BI BIOMEDICINSK VENTURE III, MERIFIN CAPITAL N.V. AND K NOMINEES LIMITED
HSBC BANK PLC